Skip to content

Medical-device intelligence

LTJ: Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA product code LTJ: Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LTJ
FDA device name
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
Device class
2
Regulation number
866.6010
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

34 clearance records and 12 recall records in the covered releases, across 26 source company names and 1 product codes. Dated history runs from Mar 19, 1997 to Jan 5, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202501
December 202500
January 202610
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

46 matching records
Device / recordCompany in FDA recordSourceSource date
BAYER PSA ASSAYK994221 · LTJBayer Corp.510(k)Apr 13, 2000FDA decision date
MODOFICATION TO VITRO IMMUNODIAGNOSTIC PRODUCTS PSA REAGENT PACK, VITRO IMMUNODIAGNOSTIC PRODUCTS PSA CALIBRATORSK000566 · LTJOrtho-Clinical Diagnostics, Inc.510(k)Mar 9, 2000FDA decision date
QUALISYS PSA IMMUNOASSAYK990234 · LTJQualisys Diagnostics, Inc.510(k)Jul 8, 1999FDA decision date
VITROS IMMUNODIAGNOSTIC PRODUCTS PSA CALIBRATORS, VITROS IMMUNODIAGNOSTIC PRODUCTS PSA REAGENT PACKK984289 · LTJOrtho-Clinical Diagnostics, Inc.510(k)Mar 12, 1999FDA decision date
ELECSYS PSA, MODEL # ELECSYS 1010K982948 · LTJBoehringer Mannheim Corp.510(k)Oct 27, 1998FDA decision date
ELECSYS PSA, MODEL 2010K982949 · LTJBoehringer Mannheim Corp.510(k)Oct 27, 1998FDA decision date
BIOCIRCUITS IOS PROSTATE SPECIFIC ANTIGEN (PSA) TEST CARTRIDGES, BIOCIRCUITS IOS PSA CONTROLSK981634 · LTJBiocircuits Corp.510(k)Oct 13, 1998FDA decision date
ACS:CENTAUR PSA2 IMMUNOASSAYK981839 · LTJChiron Diagnostics Corp.510(k)Aug 12, 1998FDA decision date
ACTIVE PSA ELISA (DSL-10-9700)K973243 · LTJDiagnostic Systems Laboratories, Inc.510(k)Aug 3, 1998FDA decision date
ACTIVE PSA IRMA (DSL-9700)K973244 · LTJDiagnostic Systems Laboratories, Inc.510(k)Aug 3, 1998FDA decision date
THE COMPLEXED PSA ASSAY FOR THE BAYER IMMUNO 1 SYSTEMK980376 · LTJBayer Corp.510(k)Apr 23, 1998FDA decision date
IMMULITE 2000 3RD GENERATION PSAK974842 · LTJDiagnostic Products Corp.510(k)Apr 21, 1998FDA decision date
ADVANTAGE CHEMILUMINESCENCE PROSTATE SPECIFIC ANTIGEN (PSA) IMMUNOASSAYK980716 · LTJNichols Institute Diagnostics510(k)Apr 3, 1998FDA decision date
ACCESS(R) PSA REAGENTS ON THE ACCESS(R) IMMUNOASSAY ANALYZER 33220, 33225, 33229K974816 · LTJBeckman Instruments, Inc.510(k)Feb 20, 1998FDA decision date
ELECSYS PSA (ON ELECSYS 1010)K974189 · LTJBoehringer Mannheim Corp.510(k)Jan 6, 1998FDA decision date
IMMULITE THIRD GENERATION PSA (LKUPI,LKUP5)K972021 · LTJDiagnostic Products Corp.510(k)Oct 31, 1997FDA decision date
PROSTATE SPECIFIC ANTIGEN METHODK973101 · LTJDade Chemistry Systems, Inc.510(k)Sep 18, 1997FDA decision date
IMMULITE 2000 PSAK972095 · LTJDiagnostic Products Corp.510(k)Aug 22, 1997FDA decision date
ELECSYS PSA ASSAYK964351 · LTJBoehringer Mannheim Corp.510(k)Jul 25, 1997FDA decision date
OPUS PSA TEST SYSTEMK964595 · LTJBehring Diagnostics, Inc.510(k)Jun 24, 1997FDA decision date
ENZYMUN-TEST PSAK965085 · LTJBoehringer Mannheim Corp.510(k)Mar 19, 1997FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗